Fact CheckerSign in

NCT05072730Completed

ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2

Super High-Pressure Balloon Versus Intravascular Lithotripsy for Severely Calcified Coronary Lesions: The ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions (ISAR-CALC) 2 Randomized Trial

Source: ClinicalTrials.gov · Last updated 13 Jul 2026

Brief summary (registry, in English)

The ISAR-CALC 2 trial is an investigator-initiated, prospective, randomized, multicenter, assessors-blind, open-label other clinical investigation. The objective of this trial is to investigate final angiographic minimal lumen diameter (MLD) following a strategy of super high-pressure balloon (OPN NC) versus intravascular lithotripsy (IVL) for drug-eluting stent (DES) implantation in severely calcified coronary lesions.

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
18 Jun 2021
Start date
1 Dec 2022
Primary completion date
21 May 2026
Lead sponsor
Deutsches Herzzentrum Muenchen
NCT number
NCT05072730

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 1 Dec 2022 to the primary completion date, 21 May 2026
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Limited long-term prognosis due to other comorbid conditions with life expectancy \<12 months

Other

  • Target lesion is located in a coronary artery bypass graft
  • Target lesion is an in-stent restenosis
  • Target lesion is a chronic total occlusion
  • Target vessel thrombus

Who the study is looking for

  • Age above 18 years and able to give consent
  • Persistent angina despite medical therapy and/or evidence of inducible ischemia
  • De-novo lesion in a native coronary artery
  • Target reference vessel diameter or intended stent diameter ≥2.50 or ≤4.00 mm by visual estimation
  • Severe calcification of the target lesion as determined by visual estimation at coronary angiography
  • Unsuccessful lesion preparation with standard non-compliant balloon (\< 30% reduction of baseline diameter stenosis at maximal pressure)
  • Written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Herz- und Diabeteszentrum NRW Universitätsklinikum der Ruhr-Universität Bochum
Coordinator of this site? Confirm its status
Bad OeynhausenGermanyUnknown status
Helios Klinikum Erfurt
Coordinator of this site? Confirm its status
ErfurtGermanyUnknown status
Universitätsklinikum Frankfurt
Coordinator of this site? Confirm its status
Frankfurt am MainGermanyUnknown status
Universitätsklinikum Jena
Coordinator of this site? Confirm its status
JenaGermanyUnknown status
MediClin Herzzentrum Lahr
Coordinator of this site? Confirm its status
LahrGermanyUnknown status
Deutsches Herzzentrum Muenchen
Coordinator of this site? Confirm its status
MünchenGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.